UNSPSC 51183701: Ciglitazone

This classification denotes an anti-diabetic agent with the molecular formula C18H23NO3S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier (SRS UNII) U8QXS1WU8G, chemically known as 2,4-thiazolidinedione, 5-((4-((1-methylcyclohexyl)methoxy)phenyl)methyl)-, (+-)- but more generally known as ciglitazone, which bears US NIH Compound Identifier 2750. European Medicines Agency schedules Ciglitazone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06260MIG.

UNSPSC 51183701 Ciglitazone (Commodity) covers diabetes pharmaceutical products, though state and local procurement activity under this code clusters within broader multi-source generic pharmaceutical aggregations rather than single-molecule acquisitions. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by the Minnesota Department of Administration's Office of State Procurement, is the primary recent issuing body, soliciting generic pharmaceuticals and OTC products for distribution across state and local government health facilities in participating jurisdictions including Oregon. Work under this code involves manufacturers providing comprehensive pharmaceutical product information indexed to National Drug Codes (NDC), stock-keeping units (SKUs), universal product codes (UPCs), and specific packaging configurations, with vendors required to certify compliance with current Good Manufacturing Practices (cGMP) and the Drug Supply Chain Security Act (DSCSA), maintain contractual relationships with authorized wholesalers including AmerisourceBergen Drug Corporation (Cencora), Cardinal Health, and Morris & Dickson Co., LLC, and demonstrate pricing flexibility across flat-price, net-price, and WAC-minus formats. The issuing body is a multi-state cooperative purchasing vehicle, which signals potential for regional or national scope once contracts are awarded.

MMCAP's RFP for generic multi-source pharmaceuticals and OTC products was posted January 20, 2026, with proposals due March 26, 2026. Evaluation weights pricing competitiveness (75 percent), fixed contract pricing (10 percent), compliance with administrative data-format requirements (5 percent), EDI capability (5 percent), and agreement to a 3 percent administrative fee (5 percent). The contract term is two years for new vendors with optional extensions at MMCAP's discretion, and incumbent vendors' amendments extend through June 30, 2028. All products must be available in the marketplace by May 15, 2026, with awarded vendors then provided to authorized wholesalers and contracts effective July 1, 2026. Specific dollar values or budget ranges are not disclosed, but vendors must carry commercial general liability insurance of $5,000,000 per occurrence, network security and privacy liability of $2,000,000, and professional liability of $2,000,000, and must comply with performance penalties ranging from $200 to $1,500 per violation.